Generics 4

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Acitretin manufacturers

4 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

4 products found

acitretin

Capsules 10 mg, 25 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA, EU GMP
Unavailable markets
Canada , Peru
Available for
Licensing with supply, Distribution only
Comments
Bio study is performed against the UK RLD. Also available for Latin America, Emerging Market.
Manufacturer #16394
This healthcare company is a prominent player in the pharmaceutical industry, specializing in a wide range of products including Active Pharmaceutical Ingredients (APIs), Biosimilars, Injectables, Ophthalmics, Peptides, and Solid Orals. They have a strong presence in both domestic and international markets, particularly in the EU and North America. The company boasts a diverse portfolio across several key therapy areas, with particular strength in Cardiovascular health and Oral Anti-Diabetic (OAD) medications. Their manufacturing facilities adhere to stringent GMP certifications, ensuring high quality standards. They also hold numerous product patents, highlighting their commitment to innovation.

Manufacturer usually replies in 11 days

acitretin

Capsules 10 mg, 25 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #17331
This company has been operating in the pharmaceutical industry for over five decades, demonstrating a strong commitment to healthcare solutions. They specialize in manufacturing finished dosage formulations, biosimilars, and API/DC granules, catering to diverse needs within the healthcare market. Their focus on research and development drives innovation and ensures high-quality products, while their commitment to regulatory compliance ensures patient safety and efficacy. They possess extensive experience in the pharmaceutical industry, with a global reach and a strong presence in key regions like Asia and North America. Their production lines are compliant with EU and US GMP standards, reflecting their dedication to quality and adherence to international best practices. Key therapy areas include oncology, cardiology, and other areas where biosimilars are widely used. They offer a variety of dosage forms including solids, liquids, and injectables. While specific product patents are not explicitly mentioned, their focus on innovation and research suggests they actively pursue intellectual property protection for their offerings.

Manufacturer usually replies in 8 days

acitretin

Capsules 10 mg, 25 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401
This pharmaceutical company has two decades of experience manufacturing cost-effective medications across various therapeutic areas. Their product portfolio includes tablets, capsules, injectables, liquid orals, and topical solutions. They specialize in expert formulation development and possess advanced analytical capabilities to ensure quality and regulatory compliance. The company's key markets include the EU and North America. Their GMP certified manufacturing facility is strategically located near a major commercial hub.

Manufacturer usually replies in 5 days

Want to see all 4 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Acitretin is a retinoid medication used to treat pityriasis rubra pilaris, psoriasis, and psoriatic arthritis. It is a highly effective pharmaceutical, typically used only for severe cases of psoriasis. Suppliers of acitretin market the drug in the form of 10mg and 25mg capsules.
Following medical approval in 1994, the earliest manufacturer of acitretin medications was Allergan. Other producers and vendors have since joined the acitretin market with their formulations. As of now, the global market is relatively consolidated, populated by a limited number of pharmaceutical companies. Among the largest acitretin manufacturers are Actavis, GlaxoSmithKline, Mylan, and Teva.
Acitretin suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified acitretin manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.
The retail prices per 30 (10mg) capsules of Acitretin is typically approximate to 25,00 EUR to 30,00 EUR.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation